Goldman Sachs Downgrades Aetna (AET) to Sell
More News related to AET
- Aetna Helps Consumer-Directed Health Plan Members Maximize Their Health Benefits
- Aetna Better Health Helps Hartford Student Advocate for Improved Diabetes Care and Health Literacy
- Delaware Physicians Care Named One of Top Medicaid Plans In the Nation by U.S. News & World Report/ NCQA
- New Agreement for Hartford Healthcare and Aetna
- Aetna (AET) volatility low into Senate health reform bill and analyst meeting
More News related to Downgrades
- Davenport Downgrades Nokia (NOK) to Neutral
- Sidoti & Co Downgrades Innophos Holdings (IPHS) to Neutral
- Sidoti & Co Downgrades Tyler Technologies (TYL) to Neutral
- China BAK (CBAK) Shares Tumble Amid Q4 Results, Roth Capital Downgrade
- Canaccord Adams Downgrades Micromet (MITI) to Hold
Goldman Sachs downgrades Aetna Inc. (NYSE: AET) from Neutral to Sell.
Aetna, Inc. operates as a diversified health care benefits company primarily in the United States and Canada.
Related Categories
DowngradesStocks Mentioned
-0.06Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
